litlas
ログインアカウント作成

Massimo Cristofanilli

2001–2025 年に発表

253
論文数
50,042
被引用数
110
h 指数
241
i10 指数

被引用数

Massimo Cristofanilli の年別被引用数1926 年: 被引用 1 件1964 年: 被引用 3 件1971 年: 被引用 1 件1994 年: 被引用 1 件2001 年: 被引用 3 件2002 年: 被引用 18 件2003 年: 被引用 56 件2004 年: 被引用 83 件2005 年: 被引用 96 件2006 年: 被引用 169 件2007 年: 被引用 249 件2008 年: 被引用 283 件2009 年: 被引用 347 件2010 年: 被引用 439 件2011 年: 被引用 455 件2012 年: 被引用 432 件2013 年: 被引用 443 件2014 年: 被引用 450 件2015 年: 被引用 434 件2016 年: 被引用 497 件2017 年: 被引用 508 件2018 年: 被引用 566 件2019 年: 被引用 2,009 件2020 年: 被引用 2,172 件2021 年: 被引用 2,014 件2022 年: 被引用 1,682 件2023 年: 被引用 1,225 件2024 年: 被引用 1,802 件2025 年: 被引用 1,008 件2026 年: 被引用 28 件1927〜1963 年は被引用が無いため表示していません1965〜1970 年は被引用が無いため表示していません1972〜1993 年は被引用が無いため表示していません1995〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,818 件、この内訳の 26.7%中国: 引用元論文 2,287 件、この内訳の 12.7%イタリア: 引用元論文 1,085 件、この内訳の 6%イギリス: 引用元論文 949 件、この内訳の 5.3%ドイツ: 引用元論文 873 件、この内訳の 4.8%フランス: 引用元論文 776 件、この内訳の 4.3%スペイン: 引用元論文 602 件、この内訳の 3.3%カナダ: 引用元論文 508 件、この内訳の 2.8%日本: 引用元論文 459 件、この内訳の 2.5%オーストラリア: 引用元論文 438 件、この内訳の 2.4%インド: 引用元論文 400 件、この内訳の 2.2%韓国: 引用元論文 387 件、この内訳の 2.1%
0%26.7%その他 24.9%

機関

分野

  • Medicine53.2%
  • Biochemistry, Genetics and Molecular Biology37.2%
  • Engineering3%
  • Immunology and Microbiology2.9%
  • Computer Science0.9%
  • Materials Science0.8%
  • その他2%

トピック

  • Cancer Cells and Metastasis8%
  • Cancer Genomics and Diagnostics6.2%
  • Breast Cancer Treatment Studies6.1%
  • Advanced Breast Cancer Therapies5.5%
  • HER2/EGFR in Cancer Research4.8%
  • Cancer-related Molecular Pathways2.7%
  • その他66.7%

共著者

全論文

検索で開く
  1. Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

    著者: Massimo Cristofanilli, Nicholas C. Turner, Igor Bondarenko, Jungsil Ro, Seock‐Ah Im, Norikazu Masuda, Marco Colleoni, Angela DeMichele, Sherene Loi, Sunil Verma, Hiroji Iwata, Nadia Harbeck, Ke Zhang, Kathy Puyana Theall, Yuqiu Jiang, Cynthia Huang Bartlett, María Koehler, Dennis J. Slamon - The Lancet Oncology 2016 被引用: 1,822

  2. Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer

    著者: Nicholas C. Turner, Dennis J. Slamon, Jungsil Ro, Igor Bondarenko, Seock‐Ah Im, Norikazu Masuda, Marco Colleoni, Angela DeMichele, Sherene Loi, Sunil Verma, Hiroji Iwata, Nadia Harbeck, Sibylle Loibl, Fabrice André, Kathy Puyana Theall, Xin Huang, C. Giorgetti, Cynthia Huang Bartlett, Massimo Cristofanilli - New England Journal of Medicine 2018 被引用: 1,293

  3. Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

    著者: Massimo Cristofanilli, G. Thomas Budd, Matthew J. Ellis, Alison Stopeck, Jeri Matera, Michael Craig Miller, James M. Reuben, Gerald V. Doyle, W. Jeffrey Allard, Leon W.M.M. Terstappen, Daniel F. Hayes - New England Journal of Medicine 2004 被引用: 4,584

  4. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

    著者: Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess, Fabrice André, Attila Tordai, Jaime Mejia, W. Fraser Symmans, Ana M. González-Angulo, Bryan T. Hennessy, Marjorie Green, Massimo Cristofanilli, Gabriel N. Hortobágyi, Lajos Pusztai - Journal of Clinical Oncology 2008 被引用: 2,906

  5. Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

    著者: Nicholas C. Turner, Jungsil Ro, Fabrice André, Sherene Loi, Sunil Verma, Hiroji Iwata, Nadia Harbeck, Sibylle Loibl, Cynthia Huang Bartlett, Ke Zhang, C. Giorgetti, Sophia Randolph, María Koehler, Massimo Cristofanilli - New England Journal of Medicine 2015 被引用: 1,586

  6. The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial

    著者: Ben O’Leary, Rosalind Cutts, Yuan Liu, Sarah Hrebien, Xin Huang, Kerry Fenwick, Fabrice André, Sibylle Loibl, Sherene Loi, Isaac García-Murillas, Massimo Cristofanilli, Cynthia Huang Bartlett, Nicholas C. Turner - Cancer Discovery 2018 被引用: 667

  7. Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives

    著者: Eleonora Nicolò, Federica Giugliano, Liliana Ascione, Paolo Tarantino, Chiara Corti, Sara M. Tolaney, Massimo Cristofanilli, Giuseppe Curigliano - Cancer Treatment Reviews 2022 被引用: 213

  8. The Landscape of Targeted Therapies in TNBC

    著者: Elena Vagia, Devalingam Mahalingam, Massimo Cristofanilli - Cancers 2020 被引用: 451

  9. Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor–Positive Metastatic Breast Cancer

    著者: Nicholas C. Turner, Yuan Liu, Zhou Zhu, Sherene Loi, Marco Colleoni, Sibylle Loibl, Angela DeMichele, Nadia Harbeck, Fabrice André, Mohamed Amine Bayar, Stefan Michiels, Zhe Zhang, C. Giorgetti, Mónica Arnedos, Cynthia Huang Bartlett, Massimo Cristofanilli - Journal of Clinical Oncology 2019 被引用: 464

  10. ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer

    著者: Rokana Taftaf, Xia Liu, Salendra Singh, Yuzhi Jia, Nurmaa K. Dashzeveg, Andrew D. Hoffmann, Lamiaa El-Shennawy, Erika K. Ramos, Valery Adorno-Cruz, Emma J. Schuster, David Scholten, Dhwani Patel, Youbin Zhang, Andrew A. Davis, Carolina Reduzzi, Yue Cao, Paolo D’Amico, Yang Shen, Massimo Cristofanilli, William A. Müller, Vinay Varadan, Huiping Liu - Nature Communications 2021 被引用: 265

  11. Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models

    著者: Xia Liu, Rokana Taftaf, Madoka Kawaguchi, Ya-Fang Chang, Wenjing Chen, David Entenberg, Youbin Zhang, Lorenzo Gerratana, Simo Huang, Dhwani Patel, Elizabeth Tsui, Valery Adorno-Cruz, Steven M. Chirieleison, Yue Cao, Allison S. Harney, Shivani Patel, Antonia Patsialou, Yang Shen, Stefanie Avril, Hannah Gilmore, Justin D. Lathia, Derek W. Abbott, Massimo Cristofanilli, John S. Condeelis, Huiping Liu - Cancer Discovery 2018 被引用: 411

  12. Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2− ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study

    著者: Massimo Cristofanilli, Hope S. Rugo, Seock‐Ah Im, Dennis J. Slamon, Nadia Harbeck, Igor Bondarenko, Norikazu Masuda, Marco Colleoni, Angela DeMichele, Sherene Loi, Hiroji Iwata, Ben O’Leary, Fabrice André, Sibylle Loibl, Eustratios Bananis, Yuan Liu, Xin Huang, Sindy Kim, Maria Jose Lechuga Frean, Nicholas C. Turner - Clinical Cancer Research 2022 被引用: 198

  13. Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer

    著者: Charlotte Fribbens, Ben O’Leary, Lucy Kilburn, Sarah Hrebien, Isaac García-Murillas, Matthew Beaney, Massimo Cristofanilli, Fabrice André, Sherene Loi, Sibylle Loibl, John Jiang, Cynthia Huang Bartlett, María Koehler, Mitch Dowsett, Judith M. Bliss, Stephen Johnston, Nicholas C. Turner - Journal of Clinical Oncology 2016 被引用: 718

  14. Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Zefei Jiang, Wei Li, Xichun Hu, Qingyuan Zhang, Tao Sun, Shude Cui, Shusen Wang, Quchang Ouyang, Yongmei Yin, Cuizhi Geng, Zhongsheng Tong, Ying Cheng, Yueyin Pan, Yuping Sun, Hong Wang, Tao Ouyang, Kangsheng Gu, Jifeng Feng, Xiaojia Wang, Shubin Wang, Tianshu Liu, Jinghua Gao, Massimo Cristofanilli, Zhiqiang Ning, Xianping Lu - The Lancet Oncology 2019 被引用: 267

  15. Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer

    著者: Rinath Jeselsohn, Roman Yelensky, Gilles Buchwalter, Garrett M. Frampton, Funda Meric‐Bernstam, Ana M. González-Angulo, Jaime Ferrer-Lozano, José Alejandro Pérez Fidalgo, Massimo Cristofanilli, Henry Gómez, Carlos L. Arteaga, Jennifer M. Giltnane, Justin M. Balko, Maureen Cronin, Mirna Jarosz, James Sun, Matthew Hawryluk, Doron Lipson, Geoff Otto, Jeffrey S. Ross, Addie Dvir, Lior Soussan‐Gutman, Ido Wolf, Tamar Rubinek, Lauren Gilmore, Stuart J. Schnitt, Steven E. Come, Lajos Pusztai, Philip Stephens, Myles Brown, Vincent A. Miller - Clinical Cancer Research 2014 被引用: 662

  16. Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

    著者: Luigi Formisano, Yao Lu, Alberto Servetto, Ariella B. Hanker, Valerie M. Jansen, Joshua A. Bauer, Dhivya R. Sudhan, Ángel Guerrero‐Zotano, Sarah Croessmann, Yan Guo, Paula I. González-Ericsson, Kyung‐min Lee, Mellissa J. Nixon, Luis J. Schwarz, Melinda E. Sanders, Teresa C. Dugger, Marcelo Cruz, Amir Behdad, Massimo Cristofanilli, Aditya Bardia, Joyce O’Shaughnessy, Rebecca J. Nagy, Richard B. Lanman, Nadia Solovieff, Wei He, Michelle C. Miller, Fei Su, Yu Shyr, Ingrid A. Mayer, Justin M. Balko, Carlos L. Arteaga - Nature Communications 2019 被引用: 419

  17. Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2–Negative Metastatic Breast Cancer

    著者: Anne F. Schott, Lori J. Goldstein, Massimo Cristofanilli, Pier Adelchi Ruffini, Susan McCanna, James M. Reuben, Raymond P. Perez, Giraldo Kato, Max S. Wicha - Clinical Cancer Research 2017 被引用: 240

  18. Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

    著者: Ben O’Leary, Sarah Hrebien, James P. Morden, Matthew Beaney, Charlotte Fribbens, Xin Huang, Yuan Liu, Cynthia Huang Bartlett, María Koehler, Massimo Cristofanilli, Isaac García-Murillas, Judith M. Bliss, Nicholas C. Turner - Nature Communications 2018 被引用: 420

  19. PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer

    著者: Erica L. Mayer, Yue Ren, Nikhil Wagle, Reshma Mahtani, X. Cynthia, Angela DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D. Miller, Yara Abdou, Elizabeth C. Riley, Rubina Qamar, Priyanka Sharma, Sonya Reid, Natalie Sinclair, Meredith Faggen, Caroline Block, Naomi Y. Ko, Ann H. Partridge, Wendy Y. Chen, Michelle K. DeMeo, Victoria Attaya, Amanda Okpoebo, Jillian Alberti, Yuan Liu, Eric Gauthier, Harold J. Burstein, Meredith M. Regan, Sara M. Tolaney - Journal of Clinical Oncology 2024 被引用: 109

  20. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

    著者: Sabine Riethdorf, Herbert A. Fritsche, Volkmar Müller, Thomas Rau, Christian Schindlbeck, Brigitte Rack, Wolfgang Janni, Cornelia Coith, Katrin Beck, F. Jänicke, Summer Jackson, Terrie G. Gornet, Massimo Cristofanilli, Klaus Pantel - Clinical Cancer Research 2007 被引用: 1,337

  21. Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer

    著者: Massimo Cristofanilli, Daniel F. Hayes, G. Thomas Budd, Mathew J. Ellis, Alison Stopeck, James M. Reuben, Gerald V. Doyle, Jeri Matera, W. Jeffrey Allard, Michael Craig Miller, Herbert A. Fritsche, Gabriel N. Hortobágyi, Leon W.M.M. Terstappen - Journal of Clinical Oncology 2005 被引用: 1,135

  22. Design of SERENA-6, a phase III switching trial of camizestrant in ESR1 -mutant breast cancer during first-line treatment

    著者: Nicholas C. Turner, Cynthia Huang Bartlett, Kevin Kalinsky, Massimo Cristofanilli, Giampaolo Bianchini, Stephen Chia, Hiroji Iwata, Wolfgang Janni, X. Cynthia, Erica L. Mayer, Yeon Hee Park, Stephen B. Fox, Xiaochun Liu, Sasha McClain, François‐Clément Bidard - Future Oncology 2023 被引用: 78

  23. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

    著者: Massimo Cristofanilli, Jean‐Yves Pierga, James M. Reuben, Alfred Rademaker, Andrew A. Davis, Dieter Peeters, Tanja Fehm, Franco Nolè, Rafael Gisbert‐Criado, Dimitriοs Mavroudis, Salvatore Grisanti, Mario Giuliano, José Á. García-Sáenz, Justin Stebbing, Carlos Caldas, Paola Gazzaniga, Luís Manso, Rita Zamarchi, Ángela Fernández de Lascoiti, Leticia De Mattos‐Arruda, Michail Ignatiadis, Luc Cabel, Steven Van Laere, F Meier-Stiegen, Maria Teresa Sandri, José Vidal-Martínez, Eleni Politaki, Francesca Consoli, Daniele Generali, Maria Rosa Cappelletti, Eduardo Díaz‐Rubio, Jonathan Krell, Sarah‐Jane Dawson, Cristina Raimondi, Annemie Rutten, Wolfgang Janni, Elisabetta Munzone, Vicente Carañana, Sofia Agelaki, Camillo Almici, Luc Dirix, Erich‐Franz Solomayer, Laura Zorzino, Lauren Darrigues, Jorge S. Reis‐Filho, Lorenzo Gerratana, Stefan Michiels, François‐Clément Bidard, Klaus Pantel - Critical Reviews in Oncology/Hematology 2018 被引用: 268

  24. Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2− metastatic breast cancer

    著者: Hope S. Rugo, Adam Brufsky, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M. Layman, Massimo Cristofanilli, Mylin A. Torres, Giuseppe Curigliano, Richard S. Finn, Angela DeMichele - npj Breast Cancer 2022 被引用: 115